Our response to research linking maternal sugar consumption during pregnancy to allergy in the offspring.
This BSI statement is in response to a ruling by the European Court of Justice (ECJ) on national courts deciding that vaccines may cause adverse reactions, even in the absence of scientific evidence.
The BSI has released a statement in response to a new report published by the Academy of Medical Sciences entitled ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’.
Read our response to paper published in PLOS Pathogens on mutations in a strain of avian flu that could potentially allow this virus to be transmitted between humans.
Read our response to a paper published in JCI Insight on using a novel 'gene therapy' to treat allergy in mice.
Members of the public are invited to download the free #BritainBreathing app to track their seasonal allergy symptoms and to help researchers understand more about why the frequency of allergies is increasing.
A new survey has shown there are large variations in the use and interpretation of a new type of allergy test (component testing) by doctors in the UK and Europe. As a result of these findings, a new quality assurance scheme is being launched to ensure proper quality assessment and education about the performance and use of the tests. The paper was published in Clinical & Experimental Immunology.
The BSI has responded to a paper looking at if antibiotic use in mid-life has an effect on the subsequent likelihood of developing bowel cancer precursor.
The BSI responded to a paper looking at the effect of reducing the use of antibiotics in farm animals on antimicrobial resistance in humans.
A paper published today in Nature Communications reports on a new approach to targeting a wide variety of viruses. In response, the BSI has issued the following statement:
Researchers have discovered a molecular mechanism that could explain why allergies are less common in developing countries. Writing in the journal, Immunology, they report that this finding could be the first step to developing new immunotherapies to prevent allergies.
A paper published today in the British Medical Journal reports on a systematic review and meta-analysis on studies assessing whether vitamin D supplementation is effective in preventing acute respiratory infections. The study concluded that vitamin D supplementation was safe and provided protection against acute respiratory tract infection, with patients who were very vitamin D deficient experiencing the most benefit. In response to this paper, the British Society for Immunology has issued the following statement:
The National Institute of Allergy and Infectious Diseases (NIAID) has published new guidelines on the early introduction of peanut-containing foods for the prevention of peanut allergy in the United States, in the Annals of Allergy, Asthma, and Immunology.
A paper published today in PLOS Computational Biology has reported on the benefits that could be gained through developing a universal vaccine against the influenza virus. Using mathematical modelling, the authors discuss the potential population-level benefits that a universal vaccine would offer over conventional seasonal vaccines. In response to this report, the BSI has issued the following statement.